Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145316 | SCV000192393 | likely benign | not specified | 2016-01-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001513159 | SCV001720708 | benign | not provided | 2023-12-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001513159 | SCV001994533 | uncertain significance | not provided | 2019-08-29 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis, which includes splice predictors and evolutionary conservation, suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Ce |
RCV001513159 | SCV002062510 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | ATR: BP4, BS2 |
Ambry Genetics | RCV002336289 | SCV002638054 | likely benign | Inborn genetic diseases | 2022-02-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003315929 | SCV004015634 | likely benign | Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing |